Global Cerebrovascular Diseases Treatment Market Research and Forecast, 2018-2023

INDORE, India - May 28, 2019 - PRLog -- According to OMR analysis, the global cerebrovascular diseases treatment market is estimated to grow at a significant CAGR during the forecast period (2018-2023). The major factors contributing to the growth of the market include increasing inherited congenital diseases and the rising aging population. Furthermore, increasing prevalence of diabetes and the increasing awareness of emerging therapies can contribute to the prominent growth of the cerebrovascular diseases treatment market in the future.

Furthermore, the global cerebrovascular diseases treatment market is segmented on the basis of type of stroke, diagnosis, treatment, end-users. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Market Segmentation

1.       Global Cerebrovascular Diseases Treatment Market by Type of Stroke

·  Ischemic

·  Haemorrhagic

2.       Global Cerebrovascular Diseases Treatment Market by Diagnosis

·  Cerebral Angiography

·  Carotid Duplex

·  Computed Tomography

·  Electroencephalogram

3.       Global Cerebrovascular Diseases Treatment Market by Treatment

·  Medication

o   Antiplatelets

o   Antihypertensives

o   Others

·  Surgical Procedure

o   Endovascular Surgery

o   Vascular Surgery

o   Others

4.       Global Cerebrovascular Diseases Treatment Market by End User

·  Hospitals

·  Surgical Clinics

·  Research Institutions

Region Covered

•  North America (US and Canada)

•  Europe (UK, Germany, France, Spain, and Italy)

•  Asia-Pacific (China, India, South Korea, and Japan)

•  Rest of the World (Middle East & Africa and Latin America)

Company Profiled

·  Actelion Pharmaceuticals Ltd.

·  Aldagen Inc.

·  Amgen Inc.

·  AstraZeneca PLC

·  Bayer AG

·  Boehringer Ingelheim International GmbH

·  Bristol-Myers Squibb

·  Daiichi Sankyo Company, Ltd.

·  F. Hoffmann-La Roche AG

·  GlaxoSmithKline PLC

·  Johnson & Johnson Inc.

·  Merck & Co., Inc.

·  Novartis International AG

·  Penumbra Inc

·  Pfizer Inc.

·  Portola Pharmaceuticals, Inc.

·  Sangamo Therapeutics, Inc.

·  Sanofi SA

·  Sihuan Pharmaceutical Holdings Group Ltd.

·  Takeda Pharmaceutical Company Ltd.

·  Tianda Pharmaceuticals Ltd.

·  United Therapeutics Corp.

·  Zocere, Inc.

A full report of global cerebrovascular diseases treatment market is available at  https://www.omrglobal.com/industry-reports/cerebrovascula...

For related reports please visit https://www.omrglobal.com/reports-category/biotechnology/

About Orion Market Research

Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.